CD8dim and NKG2D expression defines related subsets of CD4+ T cells in HIV-infected patients with worse prognostic factors

Journal of Acquired Immune Deficiency Syndromes

Volumn 51, Issue 4, 2009, Pages 390-398

  Alonso Arias, Rebeca ^a,b   López Vázquez, Antonio ^a,b   Diaz Peñ A, Roberto ^a,b   Sampere, Angeles ^a   Tricas, Lourdes ^a   Asensi, Víctor ^a   Rodrigo, Luis ^a   López Larrea, Carlos ^a,b  

^a HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^b Section of Nephrology   (Spain)

Author keywords

CD4+ CD28null; CD4+ T cells; CD8dim; CMV; Effector memory phenotype; HLA; NKG2D

Indexed keywords

CYTOTOXIC FACTOR; EFAVIRENZ; HLA DR7 ANTIGEN; INDINAVIR; NATURAL KILLER CELL RECEPTOR NKG2D; NELFINAVIR; NEVIRAPINE; PERFORIN; PROTEIN CD8DIM; RITONAVIR; SAQUINAVIR; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; CD4+ T LYMPHOCYTE; CELL EXPANSION; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DISEASE COURSE; FEMALE; FLOW CYTOMETRY; HEREDITY; HLA SYSTEM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD8; CD4-POSITIVE T-LYMPHOCYTES; CYTOMEGALOVIRUS; FEMALE; HIV INFECTIONS; HLA-DR7 ANTIGEN; HUMANS; IMMUNOPHENOTYPING; MALE; MIDDLE AGED; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY K; PROGNOSIS; T-LYMPHOCYTE SUBSETS;

EID: 68149160395     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/FTD.0b013e3181679015     Document Type: Article

References (40)

1. Von Boehmer H. The developmental biology of T lymphocytes. Ann Rev Immunol. 1990;8:531-556.
2. Zuckermann FA. Extrathymic CD4/CD8 double positive T cells. Vet Immunol Immunopathol. 1999;72:55-66.
3. Parel Y, Chizzolini C. CD4+ CD8+ double positive (DP) T cells in health and disease. Autoimmun Rev. 2004;3:215-220. (Pubitemid 38521097)
4. dim T lymphocytes exhibit enhanced cytokine expression, proliferation and cytotoxic activity in response to HCMVand HIV-1 antigens. Eur J Immunol. 2001;31:2512-2520.
5. Nascimbeni M, Shin EC, Chiriboga L, et al. Peripheral CD4+CD8+ T cells are differentiated effector memory cells with antiviral functions. Blood. 2004;104:478-486. (Pubitemid 38900031)
6. + T lymphocytes that express cytotoxicity-associated molecules and are committed to produce interferon-γ and tumor necrosis factor-α. J Infect Dis. 1998;178:1158-1162.
7. Groh V, Brühl A, El-Gabalawy H, et al. Stimulation of T cell autoreactivity by anomalous expression of NKG2D and its MIC ligands in rheumatoid arthritis. Proc Natl Acad Sci U S A. 2003;100:9452-9457. (Pubitemid 37033949)
8. Groh V, Smythe K, Dai Z, et al. Fas ligand-mediated paracrine T cell regulation by the receptor NKG2D in tumor immunity. Nat Immunol. 2006;7:755-762. (Pubitemid 43905875)
9. Azimi N, Jacobson S, Tanaka Y, et al. Immunostimulation by induced expression of NKG2D and its MIC ligands in HTLV-1-associated neurologic disease. Immunogenetics. 2006;58:252-258. (Pubitemid 43673469)
10. Capraru D, Müller A, Csernok E, et al. Expansion of circulating NKG2D+ effector memory T-cells and expression of NKG2D-ligand MIC in granulomaous lesions in Wegener's granulomatosis. Clin Immunol. 2008; 127:144-150.
11. Saez-Borderias A, Guma M, Angulo A, et al. Expression of NKG2D in CD4+ T cells specific for human cytomegalovirus. Eur J Immunol. 2006; 36:3198-3206. (Pubitemid 44932721)
12. Ward J, Bonaparte M, Sacks J, et al. HIV modulates the expression of ligands important in triggering natural killer cell cytotoxic responses on infected primary T-cell blasts. Blood. 2007;110:1207-1214. (Pubitemid 47281418)
13. CDC. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep. 1992;41:RR1-RR17.
14. Read SJ, Jeffery KJM, Bangham CRM. Aseptic meningitis and encephalitis: the role of PCR in the diagnostic laboratory. J Clin Microbiol. 1997;35:691-696.
15. Cinque P, Brytting M, Vago L, et al. Epstein-Barr virus DNA in cerebrospinal fluid from patients with AIDS-related primary lymphoma of the central nervous system. Lancet. 1993;342:398-401. (Pubitemid 23236353)
16. Secchiero P, Carrigan DR, Asano Y, et al. Detection of human herpesvirus 6 in plasma of children with primary infection and immunosuppressed patients by polymerase chain reaction. J Infect Dis. 1995;71:273-280.
17. de Oña M, Melón S, Rodriguez JL, et al. Association between human herpesvirus type 6 and type 7, and cytomegalovirus disease in heart transplant recipients. Transplant Proc. 2002;34:75-76. (Pubitemid 34311576)
18. Colombati A, Doliana R, Shiappacassi M, et al. Age-related persistent clonal expansions of CD28- cells: phenotypic and molecular TCR analysis reveals both CD4+ and CD4+CD8+ cells with identical CDR3 sequences. Clin Immunol Immunopath. 1998;89:61-70.
19. Rodriguez-Caballero A, Garcia-Montero AC, Almeida J, et al. Association between the HLA haplotype and the TCR-Vβ repertoire of anti-hCMV specific memory T-cells in immunocompetent healthy adults. Cytometry B Clin Cytom. 2007;72:371-379. (Pubitemid 350194354)
20. Garrido P, Ruiz-Cabello F, Bárcena P, et al. Monoclonal TCR-Vbeta13.1+/ CD4+/NKa+/CD8-/+dim T-LGL lymphocytosis: evidence for an antigendriven chronic T-cell stimulation origin. Blood. 2007;109:4890-4898.
21. Choi BS, Park YK, Lee JS. The CD28/HLA-DR expressions on CD4+T but not CD8+T cells are significant predictors for progression to AIDS. Clin Exp Immunol. 2002;127:137-144.
22. Ostrowski SR, Gerstoft J, Pedersen BK, et al. A low level of CD4+CD28+ T cells is an independent predictor of high mortality in human immunodeficiency virus type 1-infected patients. J Infect Dis. 2003; 187:1726-1734. (Pubitemid 36667883)
23. Lange CG, Lederman MM, Medvik K, et al. Nadir CD4+ T-cell count and numbers of CD28+ CD4+ T-cells predict functional responses to immunizations in chronic HIV-1 infection. AIDS. 2003;17:2015-2023. (Pubitemid 37297149)
24. Appay V, Zaunders JJ, Papagno L, et al. Characterization of CD4+ T CTLs ex vivo. J Immunol. 2002;168:5954-5958.
25. Snyder MR, Weyand CM, Goronzy JJ. The double life of NK receptors: stimulation or co-stimulation? Trends Immunol. 2004;25:25-32.
26. Goronzy JJ, Weyand CM. Rheumatoid arthritis. Immunol Rev. 2005;204: 55-73.
27. Van Leeuwen EMM, Remmerswaal EBM, Vossen MTM, et al. Emergence of a CD4+CD28- granzyme B+, cytomegalovirus-specific T cell subset after recovery of primary cytomegalovirus infection. J Immunol. 2004;173:1834-1841.
28. Hooper M, Kallas EG, Coffin D, et al. Cytomegalovirus seropositivity is associated with the expansion of CD4+CD28- and CD8+CD28- T cells in rheumatoid arthritis. J Rheumatol. 1999;26:1452-1457. (Pubitemid 29317864)
29. Khan N, Shariff N, Cobbold M, et al. Cytomegalovirus seropositivity drives the CD8 T cell repertoire toward greater clonality in healthy elderly individuals. J Immunol. 2002;169:1984-1992. (Pubitemid 34857662)
30. Looney RJ, Falsey A, Campbell D, et al. Role of cytomegalovirus in the T cell changes seen in elderly individuals. Clin Immunol. 1999;90: 213-219. (Pubitemid 29162167)
31. + T cells. J Immunol. 2004;172:2476-2486.
32. Fletcher JM, Vukmanovic-Stejic M, Dunne PJ, et al. Cytomegalovirus- specific CD4+ T cells in healthy carriers are continuously driven to replicative exhaustion. J Immunol. 2005;175:8218-8225. (Pubitemid 41798386)
33. Pourgheysari B, Khan N, Best D, et al. The cytomegalovirus-specific CD4+ T-cell response expands with age and markedly alters the CD4+ T-cell repertoire. J Virol. 2007;81:7759-7765. (Pubitemid 47047862)
34. Duftner C, Goldberger C, Falkenbach A, et al. Prevalence, clinical relevance and characterization of circulating cytotoxic CD4+CD28- T cells in ankylosing spondylitis. Arthritis Res Ther. 2003;5:R292-R300.
35. Thewissen M, Somers V, Venken K, et al. Analyses of immunosenescent markers in patients with autoimmune disease. Clin Immunol. 2007;123: 209-218. (Pubitemid 46590073)
36. Haynes BF, Pantaleo G, Fauci AS. Toward an understanding of the correlates of protective immunity to HIV infection. Science. 1996;271: 324-328. (Pubitemid 3021504)
37. Schrier RD, Freeman WR, Clayton AW, et al. Immune predisposition for cytomegalovirus retinitis in AIDS. J Clin Invest. 1995;95:1741-1746.
38. Blancho G, Josien R, Douillard D, et al. The influence of HLA A-B-DR matching on cytomegalovirus disease after renal transplantation. Evidence that HLA-DR7-matched recipients are more susceptible to cytomegalovirus disease. Transplantation. 1992;54:871-874.
39. Kraat YJ, Christiaans MH, Nieman FH, et al. Increased frequency of CMV infection in HLA-DR7 matched renal allograft recipients. Lancet. 1993;341:494-495.
40. Kraat YJ, Christiaans MH, Nieman FH, et al. Risk factors for cytomegalovirus infection and disease in renal transplant recipients: HLA-DR7 and triple therapy. Transpl Int. 1994;7:362-367.